Business / Reel
Business · Video brief
AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
AstraZeneca is negotiating a potential merger with Bristol Myers Squibb, aiming to form a pharmaceutical powerhouse valued at $400 billion. However, AstraZeneca's shares have fallen by over 7% during these discussions. If the merger succeed...
Video won't play? Watch on YouTube →
AstraZeneca is negotiating a potential merger with Bristol Myers Squibb, aiming to form a pharmaceutical powerhouse valued at $400 billion. However, AstraZeneca's shares have fallen by over 7% during these discussions. If the merger succeeds, it could significantly impact the oncology market.
Full story and more reels: https://newsreel.video
#news #breaking #pharma #mergers #AstraZeneca #BristolMyersSquibb
Originally reported by The Guardian.
Read the full story →
More in Business
Business
Busin
Business
Iran déjà vu: Trump once again threatens massive escalation against Tehran only to walk back
Business
Busin
Business
Why has Trump stepped in to prop up Japan’s currency?
Business
Busin
Business
0 Comments
No comments yet. Be the first.